Artificial Intelligence (AI) and Machine Learning (ML) have seen a surge in interest in recent years, with many sectors harnessing its power to accelerate innovation. Here, we examine the impact of AI and ML on the pharmaceutical sector, and its influence on patent strategies.

This content is restricted to members. To view this content please register or login below to view this content.

Register to receive up-to-date information and advice on tax developments within your industry.